Factors Related to the Development of Microalbuminuria in Children and Adolescents with Type 1 Diabetes Mellitus.
- Author:
Min Ho JUNG
1
;
Pei Tai WANG
;
Choong Ho SHIN
;
Sei Won YANG
Author Information
1. Department of Pediatrics, College of Medicine, Seoul National University, Chunggoo Sungsim Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Microalbuminuria;
Type 1 diabetes mellitus;
Chronic complications
- MeSH:
Adolescent*;
Child*;
Diabetes Mellitus, Type 1*;
Diagnosis;
Female;
Humans;
Incidence;
Male;
Mass Screening;
Prevalence;
Puberty
- From:Journal of the Korean Pediatric Society
2001;44(5):577-586
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We observed the prevalence rate of microalbuminuria(MA) and its relationship with the various clinical factors in children and adolescents with type 1 diabetes mellitus(DM). METHODS: Seventy two children and adolescents(26 males and 46 females, 17.1+/-3.0 years) were included. MA was defined as 24 hour urine microalbumin >30mg/day(20microgram/min). Subjects were classified into three groups(normoalbuminuria, transient MA, or persistent MA). Additionally, sub jects were classified into another three groups according to age at diagnosis(<5, 5-11, or >11 years), arbitrarily. Clinical characteristics were analyzed between these groups and prevalence rates of MA by age and by duration of diabetes were analyzed. RESULTS: Of the 72 patients, 42(58.3%), 11(15.3%), and 19(26.4%) patients were included in nor moalbuminuric, transient MA, and persistent MA group, respectively. The mean level of HbA1c in persistent MA group was greater than those of other groups(P<0.01). The prevalence rates of diabetic retinopathy(27.8%) and neuropathy(16.7%) in the persistent MA group were higher than those in other groups(P<0.05). The cumulative incidence for developing persistent MA was 1.4% at 13 years, 4.7% at 15 years, and 20.7% at 18 years of age. The cumulative incidence for developing persistent MA was 3.4% after 6 years, 15.6% after 7 years, and 17.8% after 8 years. In patients who were diagnosed before 11 years of age, the appearance of persistent MA was delayed until pubertal age, whereas those who were diagnosed after 11 years of age developed persistent MA earlier after diagnosis. CONCLUSION: These data suggest that screening for MA should be performed in children and adolescents who have had diabetes for more than 5 years, or have entered into puberty, especially those with poor metabolic control.
